Skip to content Skip to footer
Close
AI in Evidence Generation

How HTA Agencies Are Evaluating AI in Evidence Generation

Thought Leadership8 September 2025317Views0Likes0Comments
As AI rapidly reshapes the evidence landscape, health technology assessment (HTA) bodies are beginning to define clear expectations for its use in submissions. At CapeStart, we work closely with life sciences clients navigating these changes—especially those integrating GenAI into literature reviews, RWE generation, economic modeling, Joint Clinical Assessment (JCA) support, Clinical Evaluation Reports (CERs), Patient…

Read More

Artificial Intelligence and the Changing Landscape of Regulations in the Life Sciences

Thought Leadership5 February 2024245Views0Likes0Comments
AI has become an integral part of the life sciences landscape, contributing to advancements in diagnosis, treatment, and overall healthcare delivery. But many worry that without proper government oversight, the use of AI and machine learning (ML) algorithms could also cause negative and unintended consequences, including critical errors and bias amplification. That’s why many international…

Read More